These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32763910)

  • 21. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model.
    Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT
    Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cell(iPSC)line CJUHi001-A derived peripheral blood mononuclear cells of spinocerebellar ataxia type 1(SCA1) the CAG repeat mutation in ATXN1 gene.
    Jin Y; Nan G
    Stem Cell Res; 2023 Feb; 66():102975. PubMed ID: 36459834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1.
    Lee WS; Al-Ramahi I; Jeong HH; Jang Y; Lin T; Adamski CJ; Lavery LA; Rath S; Richman R; Bondar VV; Alcala E; Revelli JP; Orr HT; Liu Z; Botas J; Zoghbi HY
    J Clin Invest; 2022 May; 132(9):. PubMed ID: 35499073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner.
    Kim JH; Lukowicz A; Qu W; Johnson A; Cvetanovic M
    Glia; 2018 Sep; 66(9):1972-1987. PubMed ID: 30043530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Analysis and Spatiotemporal Expression of
    Vauti F; Vögele V; Deppe I; Hahnenstein ST; Köster RW
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.
    Pérez Ortiz JM; Mollema N; Toker N; Adamski CJ; O'Callaghan B; Duvick L; Friedrich J; Walters MA; Strasser J; Hawkinson JE; Zoghbi HY; Henzler C; Orr HT; Lagalwar S
    Neurobiol Dis; 2018 Aug; 116():93-105. PubMed ID: 29758256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi prevents and reverses phenotypes induced by mutant human ataxin-1.
    Keiser MS; Monteys AM; Corbau R; Gonzalez-Alegre P; Davidson BL
    Ann Neurol; 2016 Nov; 80(5):754-765. PubMed ID: 27686464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.
    Lee Y; Samaco RC; Gatchel JR; Thaller C; Orr HT; Zoghbi HY
    Nat Neurosci; 2008 Oct; 11(10):1137-9. PubMed ID: 18758459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
    Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
    Ingram M; Wozniak EAL; Duvick L; Yang R; Bergmann P; Carson R; O'Callaghan B; Zoghbi HY; Henzler C; Orr HT
    Neuron; 2016 Mar; 89(6):1194-1207. PubMed ID: 26948890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.
    Edamakanti CR; Do J; Didonna A; Martina M; Opal P
    J Clin Invest; 2018 Jun; 128(6):2252-2265. PubMed ID: 29533923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.
    Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT
    Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.
    Fujita K; Mao Y; Uchida S; Chen X; Shiwaku H; Tamura T; Ito H; Watase K; Homma H; Tagawa K; Sudol M; Okazawa H
    Nat Commun; 2017 Nov; 8(1):1864. PubMed ID: 29192206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
    Ding Y; Adachi H; Katsuno M; Sahashi K; Kondo N; Iida M; Tohnai G; Nakatsuji H; Sobue G
    Neuroscience; 2016 Jul; 327():20-31. PubMed ID: 27058144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
    Cvetanovic M; Ingram M; Orr H; Opal P
    Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.
    Goold R; Hubank M; Hunt A; Holton J; Menon RP; Revesz T; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2007 Sep; 16(17):2122-34. PubMed ID: 17599952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.
    Friedrich J; Kordasiewicz HB; O'Callaghan B; Handler HP; Wagener C; Duvick L; Swayze EE; Rainwater O; Hofstra B; Benneyworth M; Nichols-Meade T; Yang P; Chen Z; Ortiz JP; Clark HB; Öz G; Larson S; Zoghbi HY; Henzler C; Orr HT
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum.
    Ebner BA; Ingram MA; Barnes JA; Duvick LA; Frisch JL; Clark HB; Zoghbi HY; Ebner TJ; Orr HT
    J Neurosci; 2013 Mar; 33(13):5806-20. PubMed ID: 23536093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological and Functional Attenuation of Degeneration of Peripheral Neurons by Mesenchymal Stem Cell-Conditioned Medium in Spinocerebellar Ataxia Type 1-Knock-in Mice.
    Suto N; Mieda T; Iizuka A; Nakamura K; Hirai H
    CNS Neurosci Ther; 2016 Aug; 22(8):670-6. PubMed ID: 27140210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic control of ataxin-1 in multiple sclerosis.
    Ma Q; Oksenberg JR; Didonna A
    Ann Clin Transl Neurol; 2022 Aug; 9(8):1186-1194. PubMed ID: 35903875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.